RECIST (Response Evaluation Criteria in Solid Tumours) is a standardized set of criteria used to assess and measure the response of solid tumors to treatment in clinical trials. RECIST provides a consistent method for evaluating tumor size changes and categorizing responses as complete response, partial response, stable disease, or progressive disease.